Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection

Patients with cardiovascular comorbidities are more susceptible to severe infection with SARS-CoV-2, known to directly cause pathological damage to cardiovascular tissue. We outline a screening platform using human embryonic stem cell-derived cardiomyocytes, confirmed to express the protein machiner...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Thomas L., Colzani, Maria T., Macrae, Robyn G. C., Robinson, Emma L., Bloor, Stuart, Greenwood, Edward J. D., Zhan, Jun Ru, Strachan, Gregory, Kuc, Rhoda E., Nyimanu, Duuamene, Maguire, Janet J., Lehner, Paul J., Sinha, Sanjay, Davenport, Anthony P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322398/
https://www.ncbi.nlm.nih.gov/pubmed/34326460
http://dx.doi.org/10.1038/s42003-021-02453-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322398/
https://www.ncbi.nlm.nih.gov/pubmed/34326460
http://dx.doi.org/10.1038/s42003-021-02453-y

Ejemplares similares